文献速递老年慢病共病管理老年综合评估

血清谷胱甘肽水平与老年人多病共存发展速度的关联

Glutathione Serum Levels and Rate of Multimorbidity Development in Older Adults.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2020-01-01

研究基于斯德哥尔摩≥60岁人群的纵向队列(n=2,596),在基线、3年和6年随访时临床评估,用线性混合模型分析基线总血清谷胱甘肽(tGSH)与6年内多病共存发展速度的关联。结果显示基线tGSH水平与多病共存发展速度呈负相关(β×时间:-0.044,p<.001),且该关联独立于年龄、性别、教育、血清肌酐、C反应蛋白、白蛋白、体重指数、吸烟及退出或死亡时间。结论支持tGSH是多系统失调并最终导致多病共存的生物标志物这一假说。

要点

  • 基线时患≥4种慢性病者tGSH水平低于无慢性病者(3.3 vs 3.6 µmol/L,p<.001)。
  • 基线tGSH水平与6年内多病共存发展速度呈独立负相关(β×时间:-0.044,p<.001)。
  • tGSH可能反映多系统失调,是多病共存发展的潜在生物标志物。

核心结论

  • 血清tGSH水平与多病共存发展速度呈负相关,且该关联独立于特定慢性病与tGSH的关联。
  • 研究支持tGSH是多系统失调并最终导致多病共存的生物标志物这一假说。

研究设计与样本

  • 研究为基于人群的纵向研究,样本来自斯德哥尔摩≥60岁居民,共2,596人。
  • 参与者在基线、3年和6年随访时接受临床评估,多病共存以预先构建的60种疾病列表中的慢性病数量衡量。
  • 采用线性混合模型分析基线tGSH水平与6年内多病共存发展速度的关联。

主要发现

  • 基线时患≥4种疾病者tGSH水平低于无慢性病者(3.3 vs 3.6 µmol/L;p<.001)。
  • 随访中,基线tGSH水平与多病共存发展速度呈负相关(β×时间:-0.044,p<.001)。
  • 上述关联在调整年龄、性别、教育、血清肌酐、C反应蛋白、白蛋白、体重指数、吸烟及退出或死亡时间后仍存在。

临床怎么用

  • 对于老年医学科患者,可关注血清tGSH水平作为多系统失调与多病共存风险的潜在生物标志物。
  • tGSH与多病共存发展速度的负相关独立于多种混杂因素,提示其可能辅助识别多病共存高风险老年人。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We aimed to investigate the association between baseline levels of total serum glutathione (tGSH) and rate of chronic disease accumulation over time. The study population (n = 2,596) was derived from a population-based longitudinal study on ≥60-year-olds living in Stockholm. Participants were clinically assessed at baseline, 3- and 6-year follow-ups. Multimorbidity was measured as the number of chronic conditions from a previously built list of 60 diseases. Linear mixed models were applied to analyze the association between baseline tGSH levels and the rate of multimorbidity development over 6 years. We found that at baseline, participants with ≥4 diseases had lower tGSH levels than participants with no chronic conditions (3.3 vs 3.6 µmol/L; p < .001). At follow-up, baseline levels of tGSH were inversely associated with the rate of multimorbidity development (β * time: -0.044, p < .001) after adjusting for age, sex, education, levels of serum creatinine, C-reactive protein, albumin, body mass index, smoking, and time of dropout or death. In conclusion, serum levels of tGSH are inversely associated with multimorbidity development; the association exists above and beyond the link between tGSH and specific chronic conditions. Our findings support the hypothesis that tGSH is a biomarker of multisystem dysregulation that eventually leads to multimorbidity.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Pérez LM, Hooshmand B, Mangialasche F, et al. Glutathione Serum Levels and Rate of Multimorbidity Development in Older Adults. J Gerontol A Biol Sci Med Sci. 2020. PMID: 31086967. doi:10.1093/gerona/glz101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。